HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION

Brigitte Michelsen, Lykke Midtbøll Ørnbjerg, A. G. Loft, J. Sexton, A. Ciurea, H. Mann, K. Eklund, A. Yazici, M. J. Santos, J, Askling, Z. Rotar, B. Gudbjornsson, M. Pombo-Suarez, C. Codreanu, I. van der Horst-Bruinsma, E. Kristianslund, M. Nissen, K. Pavelka, N. Trokovic, N. InancE. Vieira-Sousa, D. Di Giuseppe, M. Tomsic, A. J. Geirsson, R. Ionescu, M. van de Sande, F. Iannone, C. Sánchez-Piedra, G. T. Jones, Lise Hejl Hyldstrup, N. S. Krogh, Merete Lund Hetland, Mikkel Østergaard

Original languageEnglish
Article numberFRI0403
JournalAnnals of the Rheumatic Diseases
Volume78
Issue numberSuppl. 2
Pages (from-to)887-888
Number of pages2
ISSN0003-4967
Publication statusPublished - 2019

Cite this